The current status and future directions of myxoma virus, a master in immune evasion.
about
The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppressionPoxviral ankyrin proteinsComparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptationsPseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus).A whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationMyxoma virus and the Leporipoxviruses: an evolutionary paradigm.Oncolytic Poxviruses.An overview of the lagomorph immune system and its genetic diversity.Genetic Variability of Myxoma Virus Genomes.Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.Self-disseminating vaccines for emerging infectious diseasesOncolytic myxoma virus: the path to clinicCancer and viruses: a double-edged sword.Adaptive Gene Loss? Tracing Back the Pseudogenization of the Rabbit CCL8 Chemokine.Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulenceEvolution of viral sensing RIG-I-like receptor genes in Leporidae genera Oryctolagus, Sylvilagus, and Lepus.European rabbit research in the Iberian Peninsula: state of the art and future perspectives
P2860
Q27312735-E7F87BBF-8284-4D72-81B4-6882F0744683Q28083265-94D9324D-EB31-463E-A69F-AF7679FE6DDDQ28390207-0BE1E9A4-A607-4136-BD9C-9BCA093ADD5DQ34380801-912B7DCE-B3C0-4E0C-BB4A-6BBFDC4E30D0Q34585582-8291B012-1757-4D40-84FB-649ED088C9F2Q35232793-E95458CB-26C2-44B3-AD8D-4E7CA2DA3DE8Q35234349-588CA118-CF32-4385-954B-F6F97C05A317Q35785529-FAC11D27-F8D7-4AF3-8C5B-BA6A5D9E1DF4Q36208692-7A1BF2F5-76FD-407D-AC72-D07C598E7EB5Q36295619-3A027A61-29D1-48D8-91D4-9F6C86B53B78Q36518965-F9A4ADE1-97AD-471E-A26E-5E7C0B3226D5Q37126088-4047B54E-F89B-4849-8765-326B7AA03849Q38012691-DD61B3FF-48BF-45E0-9D43-7F897D4D52B3Q39680958-53D25648-85D6-498E-A917-800613BF2DF3Q42203408-7BE47587-A28D-4634-A6FA-31F6288EAFFCQ42256141-13757546-BC4C-4D8F-A98A-B2BAAD789D64Q57247147-456755A7-E860-4D80-9573-339A66EE646A
P2860
The current status and future directions of myxoma virus, a master in immune evasion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The current status and future directions of myxoma virus, a master in immune evasion.
@en
The current status and future directions of myxoma virus, a master in immune evasion.
@nl
type
label
The current status and future directions of myxoma virus, a master in immune evasion.
@en
The current status and future directions of myxoma virus, a master in immune evasion.
@nl
prefLabel
The current status and future directions of myxoma virus, a master in immune evasion.
@en
The current status and future directions of myxoma virus, a master in immune evasion.
@nl
P2093
P2860
P356
P1433
P1476
The current status and future directions of myxoma virus, a master in immune evasion.
@en
P2093
Bart Spiesschaert
Gerlinde R Van de Walle
Katleen Hermans
P2860
P2888
P356
10.1186/1297-9716-42-76
P577
2011-06-09T00:00:00Z
P5875
P6179
1050375230